{"id":"https://openalex.org/W2396773449","doi":null,"title":"[Comparative study of the efficacy and tolerability of 0.1 and 0.03 p.100 adapalene gel and 0.025 p.100 tretinoin gel in the treatment of acne].","display_name":"[Comparative study of the efficacy and tolerability of 0.1 and 0.03 p.100 adapalene gel and 0.025 p.100 tretinoin gel in the treatment of acne].","publication_year":1996,"publication_date":"1996-01-01","ids":{"openalex":"https://openalex.org/W2396773449","mag":"2396773449","pmid":"https://pubmed.ncbi.nlm.nih.gov/8761775"},"language":"fr","primary_location":{"id":"pmid:8761775","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8761775","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annales de dermatologie et de venereologie","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061726732","display_name":"Mohsen Alireza\u00ef","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093292","display_name":"Centre Hospitalier Universitaire de Montpellier","ror":"https://ror.org/00mthsf17","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210093292"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M Alirezai","raw_affiliation_strings":["Clinique de Dermatologie, CHU de Montpellier"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinique de Dermatologie, CHU de Montpellier","institution_ids":["https://openalex.org/I4210093292"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064912875","display_name":"Jean Meynadier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Meynadier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070447748","display_name":"Stefania Jab\u0142o\u0144ska","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Jablonska","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110181721","display_name":"J. Czernielewski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Czernielewski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5004840022","display_name":"Mich\u00e8le Verschoore","orcid":"https://orcid.org/0009-0003-4353-095X","observed_orcids":["https://orcid.org/0009-0003-4353-095X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Verschoore","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.8984,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.95554906,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"123","issue":"3","first_page":"165","last_page":"70"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11013","display_name":"Skin Protection and Aging","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acne-vulgaris","display_name":"acne","score":0.8119999766349792},{"id":"https://openalex.org/keywords/adapalene","display_name":"adapalene","score":0.8460000157356262},{"id":"https://openalex.org/keywords/all-trans-retinoic-acid","display_name":"all-trans retinoic acid","score":0.996999979019165},{"id":"https://openalex.org/keywords/topical-retinoids","display_name":"topical retinoids","score":0.9470000267028809},{"id":"https://openalex.org/keywords/adapalene-gel","display_name":"adapalene gel","score":0.6990000009536743},{"id":"https://openalex.org/keywords/dose-dependent-efficacy","display_name":"dose-dependent efficacy","score":0.7039999961853027},{"id":"https://openalex.org/keywords/skin-irritation","display_name":"skin irritation","score":0.7829999923706055},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.8389999866485596},{"id":"https://openalex.org/keywords/inflammatory-lesions","display_name":"inflammatory lesions","score":0.5550000071525574},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.6240000128746033}],"concepts":[{"id":"https://openalex.org/C2777140388","wikidata":"https://www.wikidata.org/wiki/Q352348","display_name":"Adapalene","level":5,"score":0.9977028369903564},{"id":"https://openalex.org/C2777673923","wikidata":"https://www.wikidata.org/wiki/Q79928","display_name":"Acne","level":2,"score":0.8989361524581909},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.8268546462059021},{"id":"https://openalex.org/C2779963572","wikidata":"https://www.wikidata.org/wiki/Q29417","display_name":"Tretinoin","level":4,"score":0.7985386848449707},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7747228741645813},{"id":"https://openalex.org/C2779121184","wikidata":"https://www.wikidata.org/wiki/Q1166142","display_name":"Erythema","level":2,"score":0.6524544358253479},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6045234203338623},{"id":"https://openalex.org/C2775954498","wikidata":"https://www.wikidata.org/wiki/Q420418","display_name":"Retinoid","level":4,"score":0.5997087955474854},{"id":"https://openalex.org/C2777063393","wikidata":"https://www.wikidata.org/wiki/Q77776","display_name":"Irritation","level":2,"score":0.4625600576400757},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.21473532915115356},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.13810062408447266},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.1051415205001831},{"id":"https://openalex.org/C2778885487","wikidata":"https://www.wikidata.org/wiki/Q411424","display_name":"Benzoyl peroxide","level":4,"score":0.10295429825782776},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.09805363416671753},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.08470556139945984},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C44228677","wikidata":"https://www.wikidata.org/wiki/Q181898","display_name":"Polymerization","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000068816","descriptor_name":"Adapalene","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000152","descriptor_name":"Acne Vulgaris","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005782","descriptor_name":"Gels","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007641","descriptor_name":"Keratolytic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007641","descriptor_name":"Keratolytic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007641","descriptor_name":"Keratolytic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009281","descriptor_name":"Naphthalenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014212","descriptor_name":"Tretinoin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014212","descriptor_name":"Tretinoin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014212","descriptor_name":"Tretinoin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:8761775","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8761775","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annales de dermatologie et de venereologie","raw_type":"Clinical Trial"},{"id":"mag:2396773449","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8761775","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2034926383","https://openalex.org/W2044008959","https://openalex.org/W2045922860","https://openalex.org/W2399478472","https://openalex.org/W1814573375","https://openalex.org/W1992734091","https://openalex.org/W2134002686","https://openalex.org/W2132883190","https://openalex.org/W2461256686","https://openalex.org/W2070617828"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Adapalene":[1],"is":[2,250],"a":[3,26,62,95,137,220],"new":[4],"chemical":[5],"entity":[6],"with":[7,44,113,156,209,219],"retinoid":[8],"activity.":[9],"PATIENTS":[10],"AND":[11],"METHODS:":[12],"0.1":[13,83,226,245],"p.":[14,21,30,84,90,109,227,234,246],"100":[15,22,31,85,91,110,228,235,247],"adapalene":[16,23,86,111,134,164,188,210,229,248],"gel":[17,24,33,87,93,112,230,237,249],"(Diff\u00e9rine":[18],"gel),":[19],"0.03":[20,108],"and":[25,41,53,88,117,121,169,173,187,217,231],"commercially":[27],"available":[28],"0.025":[29,89,233],"tretinoin":[32,92,177,236],"(Aberel":[34],"gel)":[35],"were":[36,77,103,185,191],"compared":[37],"in":[38,66,143,159,161,174],"89":[39],"male":[40],"female":[42],"patients":[43],"acne.":[45,148],"RESULTS:":[46],"Inflammatory,":[47],"non":[48],"inflammatory,":[49],"total":[50,118],"lesion":[51,119],"counts,":[52,120],"the":[54,67,122,141,144,200],"global":[55,123],"facial":[56,124],"acne":[57,125,208],"grade":[58],"regularly":[59],"decreased":[60],"as":[61],"function":[63],"of":[64,100,129,140,147,163,176,197,199,207,225,232,244],"time":[65],"three":[68,150],"treatment":[69,146,206],"groups.":[70],"No":[71,181],"statistically":[72],"or":[73],"clinicaly":[74],"significant":[75,157],"differences":[76,128,158],"observed":[78],"for":[79,165,178],"these":[80,101],"parameters":[81],"between":[82,132],"following":[94],"12-week":[96],"treatment.":[97],"Conversely,":[98],"both":[99,133],"gels":[102,135,211],"significantly":[104],"more":[105],"effective":[106],"than":[107,193],"regards":[114],"to":[115,214],"inflammatory":[116],"grade.":[126],"The":[127,149,204,223],"efficacy":[130,224],"seen":[131],"demonstrate":[136],"dose-dependent":[138],"activity":[139],"drug":[142],"topical":[145,205],"products":[151],"induced":[152],"retinoid-like":[153],"skin":[154,242],"irritation":[155],"intensity":[160],"favour":[162,175],"erythema,":[166],"dryness,":[167],"scaling":[168],"burning":[170],"after":[171],"application":[172],"persistent":[179],"burning.":[180],"treatment-related":[182],"medical":[183],"events":[184],"reported":[186],"plasma":[189],"levels":[190],"lower":[192],"0.15":[194],"ng/ml":[195],"(limit":[196],"detection":[198],"analytical":[201],"method).":[202],"CONCLUSIONS:":[203],"was":[212],"found":[213],"be":[215],"safe":[216],"effective,":[218],"dose-related":[221],"response.":[222],"are":[238],"not":[239],"different":[240],"but":[241],"tolerance":[243],"superior.":[251]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}